Received by email:

File: 2017-07-28 - NR -BrianS Bod FINAL.pdf

                                                                           Reliq Health Technologies Inc.
                                                                         #1128   789 West Pender Street
                                                                                Vancouver, B.C., V6C 1H2
                                                                                  Phone: 778-707-6673
                                                                                     Fax: 604-608-3906



                                       NEWS RELEASE
          Brian Storseth Joins Reliq Health Technologies'
                        Board of Directors

VANCOUVER, BC, JULY 28, 2016 / - Reliq Health Technologies Inc. (TSXV: RHT OTCQB: FLNTF) ("Reliq"
or the "Company"), a technology company focused on developing innovative mobile health (mHealth)
and telemedicine solutions for Community-Based Healthcare, is pleased to have Mr. Brian Storseth join
the Company's Board of Directors effective immediately.
Mr. Storseth is a businessman and was a Member of Parliament (MP) with the Conservative Party of
Canada for 9 years from 2006 to 2015   he did not seek re-election in 2016. During his tenure as an MP,
he served on committees for Aboriginal affairs, agriculture and agri-food.
"Brian is an accomplished business leader and policy expert, having spent 9 years as an MP in the House
of Commons. Brian is intimately familiar with issues relevant to Canadian companies such as ours. We
are excited to leverage his network and experience in order to further expand Reliq's footprint in
Canada," said Dr. Lisa Crossley, CEO of Reliq Health.
"I admire how far Reliq has come in a very short period of time and am impressed with the traction the
team has achieved with their technology in the United States. I look forward to working with them to
introduce the technology to various Provinces, health authorities and other potential users. Using
technology like Reliq's to improve efficiencies, reduce costs and improve the quality of care is the future
of healthcare for publicly funded systems," said Mr. Brian Storseth.
Mr. Storseth will be granted 250,000 options at $0.15 upon approval from the TSX Venture Exchange.


ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
 Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical facts, including without limitation,
statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and
uncertainties that could cause actual and future events to differ materially from those anticipated in
such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial
operations, including technology development, anticipated revenues, projected size of market, and
other information that is based on forecasts of future results, estimates of amounts not yet
determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to
update these forward-looking statements except as required by law. These forward-looking statements
involve risks and uncertainties relating to, among other things, technology development and marketing
activities, the Company's historical experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.